ozempic and other glp 1 drugs The ABC's of GLP-1s: Benefits, Side Effects, Success Stories — Nice Healthcare Ozempic, Wegovy, Mounjaro, Trulicity, Rybelsus,

In the US, Wegovy is approved for use in individuals with a BMI over 30 with no other co-morbidities and 27 in individuals with a weight-related condition, such as hypertension

Common side effects (from clinical trial data): Nausea affects roughly 44% of users Diarrhea 30% Vomiting 24% Constipation 24% Abdominal pain 20% These are the main reasons most people stop taking these drugs

[DOI] [PubMed] [Google Scholar] 13.Steiner DF

Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus

ISTE 3a: Evaluate authenticity of scientific sources

As rates of obesity remain high in the hemophilia population, more individuals may be managing both diabetes and hemophilia